CCL11 and allergic rhinitis: In addition, Scadding et al. [67] reported that in allergic rhinitis patients who undergo immunotherapy, eotaxin-1 nasal fluid concentrations, 8 h after nasal allergen challenge, were significantly lower than in patients who did not undergo the immunotherapy.